Heng Liang

7PUBLICATIONS
30CO-AUTHORS
Molecular targetsMedical mycologyNeonatologyOther European languagesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 19, 2026
A Candidate Small Molecule Targeting Tachykinin Receptor 1 Suppresses Substance P‑Driven Extracellular Signal-Regulated Kinase Activation and Tumor Innervation in Pancreatic Cancer.

|Nov 20, 2025
Proviral Integration Site for Moloney Murine Leukemia Virus 2 Suppresses Fibronectin 1 to Drive Adhesion Loss and Epithelial-Mesenchymal Transition in Multiple Myeloma.

Junna Mai, Heng Liang, Arabella H Wan

|Oct 20, 2025
HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor-Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration.

Chuwei Liu, Heng Liang, Peipei Wang

|Apr 30, 2025
Vancomycin individual dosing regimens via Bayesian simulation: a 5-year retrospective study on preterm and term neonates.

Lu Tan, Ailing Chao, Heng Liang

|Dec 23, 2024
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients.

Changsong Wu, Jianghuan Zheng, Yanling Pan

|Jan 23, 2024
Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer.

Shaoxing Guan, Xi Chen, Yuru Wei

Pageof 2

Frequent Collaborators

3 joint publications

Guohui Wan

3 joint publications

Arabella Wan

2 joint publications

Zhi Wang

1 joint publications

Shaoxing Guan